Search

everythinglearnresearchcommunity

for

Search:↓

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Genetics play a major role in acne, but environmental factors and epigenetics also contribute.

PCOS affects many women, causing hormonal issues and health risks, but can be managed with lifestyle changes and medication.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Mutations in the AR gene cause hair thinning and loss.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Different fields of expertise must work together to better understand hair growth and create effective hair loss treatments.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Pu-erh tea reduces hair loss risk in offspring.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.